Cardiomyocyte Proliferation and Ventricular Morphogenesis

心肌细胞增殖和心室形态发生

基本信息

  • 批准号:
    9175947
  • 负责人:
  • 金额:
    $ 44.74万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-07-01 至 2020-06-30
  • 项目状态:
    已结题

项目摘要

Project Summary The epicardium has several critical functions during midgestation mouse heart development. The continuing focus of this project is to understand these processes individually and to integrate their developmental and regulatory logic with each other, with other aspects of heart development, and with the larger context of overall embryo development In Aim 1, we consider the function of epicardial mitogenic signaling that induces cardiomyocyte proliferation, and in particular address the nature of regulation of mitogen expression in the pre- and post-placental period of midgestation development. A primary goal is to confirm how ventricular chamber growth is coordinated with placental function. Our recent work established that CXCL12 is required for coronary vasculogenesis. Taking advantage of the unique features of CXCL12 as an organ-specific, arterial-specific, and paracrine-acting vascular maturation factor, in Aim 2 we propose several experimental strategies to better define the process of coronary plexus maturation, to resolve the source of coronary arterial endothelium based on requirement for CXCL12 signaling, and to develop a novel strategy to visualize the process of venous to arterial reprogramming. Although cardiomyocyte proliferation and coronary vasculogenesis are completed by birth, both are reactivated in the neonatal mouse heart after injury. In Aim 3, we examine how the same signals that support these processes in midgestation heart morphogenesis are reutilized in the neonatal heart for regeneration.
项目摘要 心外膜在妊娠中期小鼠心脏发育过程中具有几个关键功能。 本项目的持续重点是单独理解这些过程, 将它们的发育和调节逻辑与心脏的其他方面相互整合 发育,以及整个胚胎发育的更大背景 在目的1中,我们考虑心外膜有丝分裂信号诱导心肌细胞的功能, 增殖,特别是解决的性质,调节有丝分裂原表达的前, 和妊娠中期发育的胎盘后时期。主要目标是确认 心室腔生长与胎盘功能协调。 我们最近的工作确定了CXCL12是冠状动脉血管生成所必需的。以 CXCL12作为器官特异性、动脉特异性和免疫调节剂的独特特征的优势。 旁分泌作用的血管成熟因子,在目标2中,我们提出了几个实验 更好地定义冠状神经丛成熟过程的策略, 基于CXCL12信号传导的需要,并开发一种 一种新的策略来可视化静脉到动脉的重编程过程。 尽管心肌细胞增殖和冠状动脉血管发生在出生时就已完成,但两者都 在新生小鼠心脏损伤后被重新激活。在目标3中,我们研究了同样的 在妊娠中期心脏形态发生中支持这些过程的信号被重新利用, 新生儿心脏的再生。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Henry M Sucov其他文献

Henry M Sucov的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Henry M Sucov', 18)}}的其他基金

Cardiomyocyte Proliferation and Ventricular Morphogenesis
心肌细胞增殖和心室形态发生
  • 批准号:
    9927738
  • 财政年份:
    2019
  • 资助金额:
    $ 44.74万
  • 项目类别:
The complex genetics of heart regeneration
心脏再生的复杂遗传学
  • 批准号:
    10343771
  • 财政年份:
    2019
  • 资助金额:
    $ 44.74万
  • 项目类别:
The complex genetics of heart regeneration
心脏再生的复杂遗传学
  • 批准号:
    9891094
  • 财政年份:
    2019
  • 资助金额:
    $ 44.74万
  • 项目类别:
Cardiomyocyte heterogeneity and aging
心肌细胞异质性与衰老
  • 批准号:
    8883067
  • 财政年份:
    2015
  • 资助金额:
    $ 44.74万
  • 项目类别:
Cardiomyocyte heterogeneity and aging
心肌细胞异质性与衰老
  • 批准号:
    9065465
  • 财政年份:
    2015
  • 资助金额:
    $ 44.74万
  • 项目类别:
TGFb and Cardiac Neural Crest Cell Fate and Function
TGFb 和心脏神经嵴细胞的命运和功能
  • 批准号:
    7101433
  • 财政年份:
    2006
  • 资助金额:
    $ 44.74万
  • 项目类别:
TGFb and Cardiac Neural Crest Cell Fate and Function
TGFb 和心脏神经嵴细胞的命运和功能
  • 批准号:
    7599183
  • 财政年份:
    2006
  • 资助金额:
    $ 44.74万
  • 项目类别:
TGFb and Cardiac Neural Crest Cell Fate and Function
TGFb 和心脏神经嵴细胞的命运和功能
  • 批准号:
    7195088
  • 财政年份:
    2006
  • 资助金额:
    $ 44.74万
  • 项目类别:
TGFb and Cardiac Neural Crest Cell Fate and Function
TGFb 和心脏神经嵴细胞的命运和功能
  • 批准号:
    7386751
  • 财政年份:
    2006
  • 资助金额:
    $ 44.74万
  • 项目类别:
Cardiomyocyte Proliferation and Ventricular Morphogenesis
心肌细胞增殖和心室形态发生
  • 批准号:
    8845591
  • 财政年份:
    2002
  • 资助金额:
    $ 44.74万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 44.74万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.74万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 44.74万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.74万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 44.74万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 44.74万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.74万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 44.74万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 44.74万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.74万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了